Company / Share Buybacks
Moderna Share Buybacks History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$2.0M
FY2025
5-year range
$0 / $1.2B
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#40 of 48
Health Care
What the data says
Moderna's share buybacks of $2M is lower than 83% of companies in the Health Care sector (FY2025). Declined from $1.2B to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025.
Declined from $1.2B to $2M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 48This company $2.0M Sector average $611.9M
▼
-99.7% below sector average
Key checks
Key Insights
- Ranks #40 out of 48 companies in the Health Care sector.
- Peak share buybacks was recorded in FY2023.
- Lowest share buybacks in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0M | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $1.2B | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026